Cleared Traditional

K212376 - Caas Qardia

K212376 is the FDA 510(k) clearance for Caas Qardia by Pie Medical Imaging BV. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 290-day FDA review.

K212376 · Pie Medical Imaging BV · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2022
Decision
290d
Days
Class 2
Risk

K212376 is an FDA 510(k) clearance for the Caas Qardia. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Pie Medical Imaging BV (Maastricht, NL). The FDA issued a Cleared decision on May 16, 2022 after a review of 290 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Pie Medical Imaging BV devices

Submission Details

510(k) Number K212376 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 30, 2021
Decision Date May 16, 2022
Days to Decision 290 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
183d slower than avg
Panel avg: 107d · This submission: 290d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K212376.
ON3D
K221000 · 3D Ons, Inc. · May 2022
syngo Dynamics (Version VA40E)
K220832 · Siemens Medical Solutions USA, Inc. · May 2022
CoverScan v1
K212565 · Perspectum, Ltd. · May 2022
Quantib Prostate
K221106 · Quantib B.V. · May 2022
inHEART MODELS
K220727 · Inheart, Sas · May 2022
Segment 3DPrint
K211966 · Medviso AB · May 2022